Healthcare -
Biotechnology - NASDAQ - US
$ 0.492
0 %
$ 121 M
Market Cap
-1.37
P/E
SGMO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities SGMO - Sangamo Therapeutics, Inc.
37.5 M
LAST VALUE
-20.44%
2 YEAR CAGR
21.31%
5 YEAR CAGR
9.02%
10 YEAR CAGR